izpis_h1_title_alt

Tie-2, G-CSF, and leptin as promising diagnostic biomarkers for endometrial cancer : a pilot study
ID Roškar, Luka (Avtor), ID Klančič, Teja (Avtor), ID Knific, Tamara (Avtor), ID Lanišnik-Rižner, Tea (Avtor), ID Smrkolj, Špela (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (3,21 MB)
MD5: 9E833F89723BE8B309944CC14BA1C113
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2077-0383/10/4/765 Povezava se odpre v novem oknu

Izvleček
Preoperative determination of the extent of endometrial cancer (EC) would avoid the complications associated with radical surgery. Screening of patients' plasma biomarkers might enable a more precise diagnosis of EC and a tailored treatment approach. This prospective case-control monocentric pilot study included 76 postmenopausal women (38 endometrioid EC patients and 38 control patients with benign gynecological conditions), and 37 angiogenic factors (AFs) were investigated as potential biomarkers for EC. AF concentrations in preoperative plasma samples were measured using Luminex xMAP$^{TM}$ multiplexing technology. The plasma levels of sTie-2 and G-CSF were significantly lower in EC compared to control patients, whereas the plasma levels of leptin were significantly higher in EC patients. Neuropilin-1 plasma levels were significantly higher in patients with type 2 EC (grade 3) compared to patients with lower grade cancer or controls. Follistatin levels were significantly higher in patients with lymphovascular invasion, and IL-8 plasma levels were significantly higher in patients with metastases. If validated, the plasma concentrations of the indicated AFs could represent an important additional diagnostic tool for the early detection and characterization of EC. This could guide the decision-making on the extent of surgery. Further studies with larger patient numbers are currently ongoing.

Jezik:Angleški jezik
Ključne besede:endometrial cancer, angiogenesis, biomarkers, angiogenic factors, Tie-2, G-CSF, leptin
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2021
Št. strani:11 str.
Številčenje:Vol. 10, iss. 4, art. 765
PID:20.500.12556/RUL-134844 Povezava se odpre v novem oknu
UDK:616-006
ISSN pri članku:2077-0383
DOI:10.3390/jcm10040765 Povezava se odpre v novem oknu
COBISS.SI-ID:51545347 Povezava se odpre v novem oknu
Datum objave v RUL:04.02.2022
Število ogledov:1667
Število prenosov:140
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Journal of clinical medicine
Skrajšan naslov:J. clin. med.
Založnik:MDPI
ISSN:2077-0383
COBISS.SI-ID:5405759 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:15.02.2021

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:rak endometrija, angiogeneza, biomarkerji

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-8212
Naslov:Vloga intrakrinega delovanja estrogenov pri hormonsko odvisnih boleznih – pomen za zdravljenje

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-2535
Naslov:Vloga androgenov pri hormonsko odvisnih boleznih: pomen za diagnostiko in zdravljenje

Financer:Drugi - Drug financer ali več financerjev
Program financ.:University Medical Centre Ljubljana
Številka projekta:TP20190155

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj